Dishman Carbogen Amcis Ltd.

₹166.55

+ 9.05 (5.75%)

04:01 pm - close price

BSE: DCAL

NSE: DCAL

Industry: Pharmaceuticals & Drugs

House: Dishman Pharma

Overview

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 0.21Good: 5

❌

Adjusted EPS

Bad: 3Current: 0.21Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 2.31Good: 20

❌

Current Ratio

Bad: 1Current: 1.14Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 0.06Good: 15

❌

Debt to Total Assets

Bad: 1Current: 20.87Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 0.21Good: 5

❌

Adjusted EPS

Bad: 3Current: 0.21Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 2.31Good: 20

❌

Current Ratio

Bad: 1Current: 1.14Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 0.06Good: 15

❌

Debt to Total Assets

Bad: 1Current: 20.87Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	723.38	586.59	651.09	654.71	523.78
Expenditure+	601.52	525.74	609.98	592.03	494.81
Other Income+	6.53	8.47	6.05	7.16	1.43
Operating Profit	121.86	60.85	41.11	62.68	28.97
Interest	28.45	27.49	33.08	30.95	31.93
Depreciation and Amortization	70.45	75.04	80.37	85.00	70.59
Profit Before Tax	29.49	-36.26	-66.29	-49.20	-77.56
Tax+	12.49	4.64	-6.66	20.72	0.01
Net Profit	17.00	-40.90	-59.63	-69.92	-77.57

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	1912.03	2140.69	2412.92	2615.77	2711.50
Operational Expenses+	1637.82	1815.04	2080.72	2351.85	2271.77
Operating Profit	274.21	325.65	332.20	263.92	439.73
Other Income	38.59	49.14	27.77	50.79	50.89
OPM %	14.34	15.21	13.77	10.09	16.22
Depreciation and Amortisation	307.94	307.59	280.72	310.86	293.74
Interest	47.61	56.81	85.69	119.97	159.46
Profit Before Tax	-65.03	-4.25	-54.59	-122.26	19.31
Tax	80.27	8.42	-24.79	20.13	16.07
Net Profit	-165.13	18.01	-29.80	-153.45	3.24

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	8355.86	8634.20	9439.49	9570.62	9986.34
Liabilities+	8355.86	8634.20	9439.49	9570.62	9986.34

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	512.66	354.85	265.95	379.43	375.23
Cash from Investing Activity	-380.02	-618.53	-494.08	-229.52	-192.21
Cash from Financing Activity	-11.04	130.37	249.68	-22.15	-102.09
Net Cash Flow	121.60	-133.31	21.55	127.76	80.93
Opening Cash & Cash Equivalents	121.94	243.55	110.24	131.79	264.09
Closing Cash & Cash Equivalents	243.54	110.24	131.79	264.09	341.07

Shareholder Pattern

In %	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23
Promoters+	59.32	59.32	59.32	59.32	59.32	59.32	59.32	59.32	59.32	59.32
Public+	40.68	40.68	40.68	40.68	40.68	40.68	40.68	40.68	40.68	40.68
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	48481	49455	49744	50757	52822	55280	53683	50656	52336	56272

Corporate Actions

144 events in the last 3 years

Dishman Carbogen Amcis Ltd.

₹166.55

+ 9.05 (5.75%)

04:01 pm - close price

BSE: DCAL

NSE: DCAL

Industry: Pharmaceuticals & Drugs

House: Dishman Pharma

Overview

Ratios

Reported EPS

Bad: 2Current: 0.21Good: 5

❌

Adjusted EPS

Bad: 3Current: 0.21Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 2.31Good: 20

❌

Current Ratio

Bad: 1Current: 1.14Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 0.06Good: 15

❌

Debt to Total Assets

Bad: 1Current: 20.87Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 0.21Good: 5

❌

Adjusted EPS

Bad: 3Current: 0.21Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 2.31Good: 20

❌

Current Ratio

Bad: 1Current: 1.14Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 0.06Good: 15

❌

Debt to Total Assets

Bad: 1Current: 20.87Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	723.38	586.59	651.09	654.71	523.78
Expenditure+	601.52	525.74	609.98	592.03	494.81
Other Income+	6.53	8.47	6.05	7.16	1.43
Operating Profit	121.86	60.85	41.11	62.68	28.97
Interest	28.45	27.49	33.08	30.95	31.93
Depreciation and Amortization	70.45	75.04	80.37	85.00	70.59
Profit Before Tax	29.49	-36.26	-66.29	-49.20	-77.56
Tax+	12.49	4.64	-6.66	20.72	0.01
Net Profit	17.00	-40.90	-59.63	-69.92	-77.57

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	1912.03	2140.69	2412.92	2615.77	2711.50
Operational Expenses+	1637.82	1815.04	2080.72	2351.85	2271.77
Operating Profit	274.21	325.65	332.20	263.92	439.73
Other Income	38.59	49.14	27.77	50.79	50.89
OPM %	14.34	15.21	13.77	10.09	16.22
Depreciation and Amortisation	307.94	307.59	280.72	310.86	293.74
Interest	47.61	56.81	85.69	119.97	159.46
Profit Before Tax	-65.03	-4.25	-54.59	-122.26	19.31
Tax	80.27	8.42	-24.79	20.13	16.07
Net Profit	-165.13	18.01	-29.80	-153.45	3.24

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	8355.86	8634.20	9439.49	9570.62	9986.34
Liabilities+	8355.86	8634.20	9439.49	9570.62	9986.34

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	512.66	354.85	265.95	379.43	375.23
Cash from Investing Activity	-380.02	-618.53	-494.08	-229.52	-192.21
Cash from Financing Activity	-11.04	130.37	249.68	-22.15	-102.09
Net Cash Flow	121.60	-133.31	21.55	127.76	80.93
Opening Cash & Cash Equivalents	121.94	243.55	110.24	131.79	264.09
Closing Cash & Cash Equivalents	243.54	110.24	131.79	264.09	341.07

Shareholder Pattern

In %	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23
Promoters+	59.32	59.32	59.32	59.32	59.32	59.32	59.32	59.32	59.32	59.32
Public+	40.68	40.68	40.68	40.68	40.68	40.68	40.68	40.68	40.68	40.68
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	48481	49455	49744	50757	52822	55280	53683	50656	52336	56272

Corporate Actions

144 events in the last 3 years

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.